Clinical Trials Logo

Clinical Trial Summary

Background: Nearly all the yearly 3.3 million neonatal deaths occur in low and middle income countries. Infections, including those affecting the umbilical cord (omphalitis) are a significant factor in approximately a third of these deaths. In fact, the odds of all-cause mortality are 46% higher among infants with umbilical cord infection than those without infection. Five large randomized controlled trials in Asia and Sub-Saharan Africa have examined the effect of multiple applications (for at least 7 days) of 4% chlorhexidine (CHX) on the umbilical cord on omphalitis and neonatal death. These studies show a consitent positive effect of multiple applications on omphalitis but not on neonatal mortality. Whereas there is mounting evidence for the effect of 7 day chlorhexidine application, there is no data from Africa and only one study from Asia that examines the effect of a single application of CHX as soon as possible after birth. In this single Asian study, CHX led to a reduction in the risk of mild-moderate omphalitis and neonatal death. It is important, in an African setting to explore the effect of a single application, which is programmatically much simpler to implement than daily application for 7 days. Therefore, the investigators' study will compare umbilical cord cleansing with a single application of 4% chlorhexidine at birth with dry cord care in both community and facility births on omphalitis and severe illness in the neonatal period.

Methods: The chlorhexidine study is a community based, individually randomised controlled trial conducted on 4,760 mother-infant pairs in Uganda. The primary outcomes are severe illness and umbilical cord infection (omphalitis). Severe illness is defined as any illness associated with at least one of the following danger signs observed by study research assistants: inability to drink or breastfeed or (a history of) convulsions, lethargy or unconsciousness, vomiting of all feeds, and/or results in hospitalization and/or results in death.

Discussion: This study will provide novel evidence, from a Sub-Saharan African setting of the effect of umbilical cord cleansing with a single application of 4% chlorhexidine at birth in both community and facility births.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02606565
Study type Interventional
Source Makerere University
Contact Victoria Nankabirwa, MD, MPH, PhD
Phone +256755757460
Email nankabirwav@gmail.com
Status Recruiting
Phase Phase 4
Start date July 2016
Completion date December 2020

See also
  Status Clinical Trial Phase
Completed NCT01687621 - Omphalitis Community Based Algorithm Validation Study N/A
Completed NCT06002295 - A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns Phase 2
Completed NCT01751945 - Improved Accessibility of EmONC Services for Maternal and Newborn Health: a Community Based Project N/A
Completed NCT00434408 - Impact of Umbilical Cord Cleansing With 4.0% Chlorhexidine on Neonatal Mortality Phase 3
Completed NCT01528852 - Chlorhexidine Cordcare for Reduction in Neonatal Mortality and Omphalitis Phase 3
Terminated NCT02624622 - Chlorhexidine Cord Care for Newborn Infants in Kenya N/A
Terminated NCT01556867 - Evaluation of Two Strategies for Umbilical Cord Care : Dry Cord Care Versus Antiseptic on the Incidence of Omphalitis in Healthy Term Newborn N/A
Recruiting NCT04798833 - Newborn Care Kit to Save Lives in GB, Pakistan N/A
Completed NCT02694679 - Randomized Controlled Trial of Social Network Targeting in Honduras N/A
Completed NCT00682006 - Topical Application of Chlorhexidine to the Umbilical Cord for Prevention of Omphalitis and Neonatal Mortality in Rural District of Pakistan Phase 3